| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/11/2003 | WO2003102172A1 Methods and compositions for a ubiquitin map |
| 12/11/2003 | WO2003102168A1 Attenuated listeria spp. and methods for using the same |
| 12/11/2003 | WO2003102166A2 Novel flavivirus antigens |
| 12/11/2003 | WO2003102165A2 IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE |
| 12/11/2003 | WO2003102164A2 Cancer-linked gene as target for chemotherapy |
| 12/11/2003 | WO2003102161A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102156A2 Heterologous stimulus-gated ion channels and methods of using same |
| 12/11/2003 | WO2003102154A2 Improved receptor detection |
| 12/11/2003 | WO2003102149A2 Identification of a novel bhd gene |
| 12/11/2003 | WO2003102148A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 12/11/2003 | WO2003102146A2 Aptamer constructs |
| 12/11/2003 | WO2003102141A2 Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102139A2 Erbin as a negative regulator of ras-raf-erk signaling |
| 12/11/2003 | WO2003102137A2 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2003102130A2 A human cell assay to determine effect of sample compounds on col2 enhancer expression |
| 12/11/2003 | WO2003102129A2 Photorhabdus luminescens mcf toxin genes and uses thereof |
| 12/11/2003 | WO2003102127A2 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | WO2003102029A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102027A1 Homotrimeric extended obg3 globular head and uses thereof |
| 12/11/2003 | WO2003102026A1 Caudal protein recognizing e2f promoter, transformants of overexpressing caudal, and use thereof |
| 12/11/2003 | WO2003102025A1 Protein inducing cell death of helicobacter pylori |
| 12/11/2003 | WO2003102023A1 Tumour-associated peptides that bond to mhc molecules |
| 12/11/2003 | WO2003102015A2 Method and apparatus for detecting and monitoring peptides, and peptides identified therewith |
| 12/11/2003 | WO2003101497A1 Knockout mice and their use |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101475A1 Treatment of cell proliferative disorders with chlorotoxin |
| 12/11/2003 | WO2003101474A1 Combination chemotherapy with chlorotoxin |
| 12/11/2003 | WO2003101473A1 Suicide tetramers comprising mhc class i and uses thereof |
| 12/11/2003 | WO2003101398A2 Variants of antithrombin iii |
| 12/11/2003 | WO2003101397A2 Tetravalent dengue vaccines |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101388A2 Human solute carrier family 7 member 11 (hslc7a11) |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101283A2 Diagnostics markers for lung cancer |
| 12/11/2003 | WO2003101202A1 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 12/11/2003 | WO2003101201A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | WO2003101173A2 Immunomodulatory constructs and their uses |
| 12/11/2003 | WO2003080666A3 An adipocyte insulin and a method of treating diabetes |
| 12/11/2003 | WO2003076463A3 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance |
| 12/11/2003 | WO2003074685A3 Il-10 gene transfer to peripheral blood mononuclear cells |
| 12/11/2003 | WO2003074562A3 Vanilloid receptor (trpv) fusion proteins |
| 12/11/2003 | WO2003070882A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
| 12/11/2003 | WO2003066098A3 Snares and methods of controlling cytokinesis |
| 12/11/2003 | WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 12/11/2003 | WO2003065977A3 Modified antigen-presenting cells |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003062462A3 Method for isolating nucleic acids and protein from a single sample |
| 12/11/2003 | WO2003060465A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 12/11/2003 | WO2003060074A3 Novel metastasis suppressor gene on human chromosome 8 |
| 12/11/2003 | WO2003060064A3 Intracellular signaling molecules |
| 12/11/2003 | WO2003057847A3 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 12/11/2003 | WO2003052110A3 Nucleic acid nematicides |
| 12/11/2003 | WO2003052076A3 Identification of essential genes of cryptococcus neoformans and methods of use |
| 12/11/2003 | WO2003051834A3 Immunocellular receptors related to neurological disorders |
| 12/11/2003 | WO2003050542A3 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit |
| 12/11/2003 | WO2003050141A3 Calpain activators |
| 12/11/2003 | WO2003048348A3 Production of viruses, viral isolates and vaccines |
| 12/11/2003 | WO2003048304A3 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF |
| 12/11/2003 | WO2003048206A3 Growth hormone agonist peptides and their uses |
| 12/11/2003 | WO2003045986A3 Purified polypeptides involved in general metabolism as possible drug targets |
| 12/11/2003 | WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/11/2003 | WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen |
| 12/11/2003 | WO2003044039A3 Atrial natriuretic peptide clearance receptor variant associated with bone disorders |
| 12/11/2003 | WO2003038063A3 Human secreted proteins |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods |
| 12/11/2003 | WO2003033663A8 Rankl mimics and uses thereof |
| 12/11/2003 | WO2003030821A3 Albumin fusion proteins |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003029292A3 Gene regulatory peptides |
| 12/11/2003 | WO2003027312A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2003027137A3 Trimeric conjugates of peptidic derivative |
| 12/11/2003 | WO2003025225A3 Pthr1 gene polymorphisms |
| 12/11/2003 | WO2003025220A3 Fusion proteins useful for detecting analytes |
| 12/11/2003 | WO2003025218A3 Methods and yeast strains for screening antifungal agents |
| 12/11/2003 | WO2003022883A3 Use of proteins for the production of a medicament for stimulating the innate non specific immune system |
| 12/11/2003 | WO2003020888A3 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003006671A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/11/2003 | WO2003002745A3 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 12/11/2003 | WO2003002142A8 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 12/11/2003 | WO2003001882A3 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000719A3 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 12/11/2003 | WO2003000179A3 Chemically-modified progenipoietin conjugates |
| 12/11/2003 | WO2002102324A3 Anti-arthropod vector vaccines methods of selecting and uses thereof |
| 12/11/2003 | WO2002100885A3 A penta- or tetrapeptide binding to somatostatin receptors and the use of the same |
| 12/11/2003 | WO2002098914A3 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 12/11/2003 | WO2002097096A3 Nucleotide sequences which code for the metd gene |
| 12/11/2003 | WO2002097085A3 Callus specific plant promoters |
| 12/11/2003 | WO2002096940A3 Attenuated very virulent infectious bursal disease virus |
| 12/11/2003 | WO2002092785A3 Composition and methods relating to ovarian specific genes and proteins |
| 12/11/2003 | WO2002088305A3 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002079407A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002075507B1 Anti-bacterial vaccine compositions |